Nominations Open for The Medicine Maker’s 2026 Power List
October 10, 2025
Nominate your drug development and healthcare heroes for our annual celebration!
1 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Sustainability is Good Business: An Interview with Astellas
We speak with Adam Pearson, Chief Strategy Officer at Astellas, about the business of being green, success stories in Ireland, and helping local communities.
Latest News
All the latest Medicine Maker articles.
From Bitter Leaf to Big Data: African Medicinal Plants and the Future of Drug Discovery
October 7, 2025
Centuries of healing wisdom meet AI and molecular modeling, opening new possibilities for pharma pipelines.
2 min read
FOYA: Celebrating Innovation in Pharma Facilities
October 7, 2025
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
10 min read
Modernizing Studies Using AI
October 6, 2025
How can companies conduct non-interventional research more efficiently? The answer lies in AI.
3 min read
Nobel Prize for Pioneering Work on Immune Regulation
October 6, 2025
US and Japan-based researchers share 2025 Nobel Prize in Physiology or Medicine.
1 min read
The Golden Age of Drug Discovery
October 6, 2025
Sitting down with Insmed’s Tom Heightman, we discuss new technologies for drug discovery and the promise of human genome sequencing data.
7 min read
Digital Twins in Bioprocessing Explained
October 6, 2025
From identifying process deviations to accelerating scale up, digital twins offer significant advantages in bioprocessing.
6 min read
FDA Sets Science Agenda for Generics: Priorities for 2026
October 3, 2025
The FDA has unveiled its top science and research priorities for FY 2026 under the GDUFA program, including nitrosamine risk, complex drug development, bioequivalence innovations, and the use of AI and modeling to modernize generics regulation.
2 min read
A Toolkit for ICH-E6(R3)
October 3, 2025
TransCelerate and ACRO have developed a free toolkit to help with the implementation of new guidance for Good Clinical Practice. We find out more.
7 min read
Inside Sandoz’s Manufacturing Vision
October 2, 2025
We speak with an expert from Sandoz about the need to boost biosimilar manufacturing capacity in Europe.
3 min read
Digging for Antibiotics in Ancient Microbes
October 2, 2025
UPenn researchers use AI to discover thousands of potential new antibiotics from ancient microbes.
2 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.